报价延迟最少15分钟:2026/08/01 18:49 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
5.36 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.18/0.05
|
|
企业价值
77.71M
|
| 资产负债 |
|
每股账面净值
0.31
|
| 现金流量 |
|
现金流量率
0.06
|
| 损益表 |
|
收益
59.43M
|
|
每股收益
3.79
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment which is oncology services. Its research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. The company's pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. Its revenue is majorly derived from research services. |
